What if your body’s own immune system could be taught to wipe out tumours — and do it so effectively that no further ...

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the ...

Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the ...

Patients with certain types of early stage cancer, particularly those affecting the gastrointestinal system, may be able to ...

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...